[Management of antiphospholipid syndrome].
Atsumi
Tatsuya
T
D017152:Antibodies, Antiphospholipid / Q000097:blood; D000925:Anticoagulants / Q000008:administration & dosage; D016736:Antiphospholipid Syndrome / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy*; D001241:Aspirin / Q000008:administration & dosage; D015415:Biomarkers / Q000097:blood; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006493:Heparin / Q000008:administration & dosage; D006801:Humans; D016682:Lupus Coagulation Inhibitor / Q000097:blood; D008297:Male; D011247:Pregnancy; D011248:Pregnancy Complications; D014859:Warfarin / Q000008:administration & dosage
D017152:Antibodies, Antiphospholipid; D000925:Anticoagulants; D015415:Biomarkers; D016682:Lupus Coagulation Inhibitor; D014859:Warfarin; D006493:Heparin; D001241:Aspirin